Engineering of multiferroic BiFeO3 grain boundaries with head-to-head polarization configurations

Confined low dimensional charges with high density such as two-dimensional electron gas (2DEG) at interfaces and charged domain walls in ferroelectrics show gre...     

云仿真系统可信度评估问题探讨

云仿真平台支持“云仿真”模式,能够自动查找仿真资源、动态构建云仿真系统。由于云仿真平台具有按需构建仿真服务、多粒度资源共享等特点,云仿真系统的可信度评估工作在仿真资源的可信度、仿真子系统的可信度、仿真运行环境的可靠性等方面面临新的问题。从云仿真系统全生命周期角度,建立了云仿真系统的可信度评估过程模型和云仿真系统可信度评估指标体系,并给出了一种仿真资源排序评估方法,为云仿真系统可信度评估工作提供参考。     

汽轮机通流部分清洗技术在6MW机组中的应用

通过对霍州煤电煤矸石热电厂2#汽轮机组推力瓦温度高原因分析,得出其主要原因为通流部分结垢严重,流通不畅,导致汽轮机做功能力下降,使机组无法带至额定负荷;并对通流部分结垢的原因进行分析、研究,作出清洗处理,有效降低了机组运行中的推力瓦温度,以提高机组的安全经济性。     

求解变分不等式与不动点问题的惯性次梯度外梯度算法

提出了一种求解变分不等式与不动点问题的惯性次梯度外梯度算法,证明了其弱收敛性定理,通过数值实验验证所得的理论结果.     

The emerging link between O-GlcNAcylation and neurological disorders

O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) is involved in the regulation of many cellular cascades and neurological diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and stroke. In the brain, the expression of O-GlcNAcylation is notably heightened, as is that of O-linked N-acetylglucosaminyltransferase (OGT) and β-N-acetylglucosaminidase (OGA), the presence of which is prominent in many regions of neurological importance. Most importantly, O-GlcNAcylation is believed to contribute to the normal functioning of neurons; conversely, its dysregulation participates in the pathogenesis of neurological disorders. In neurodegenerative diseases, O-GlcNAcylation of the brain’s key proteins, such as tau and amyloid-β, interacts with their phosphorylation, thereby triggering the formation of neurofibrillary tangles and amyloid plaques. An increase of O-GlcNAcylation by pharmacological intervention prevents neuronal loss. Additionally, O-GlcNAcylation is stress sensitive, and its elevation is cytoprotective. Increased O-GlcNAcylation ameliorated brain damage in victims of both trauma-hemorrhage and stroke. In this review, we summarize the current understanding of O-GlcNAcylation’s physiological and pathological roles in the nervous system and provide a foundation for development of a therapeutic strategy for neurological disorders.     

Melatonin and mitochondrial function during ischemia/reperfusion injury

Ischemia/reperfusion (IR) injury occurs in many organs and tissues, and contributes to morbidity and mortality worldwide. Melatonin, an endogenously produced indolamine, provides a strong defense against IR injury. Mitochondrion, an organelle for ATP production and a decider for cell fate, has been validated to be a crucial target for melatonin to exert its protection against IR injury. In this review, we first clarify the mechanisms underlying mitochondrial dysfunction during IR and melatonin’s protection of mitochondria under this condition. Thereafter, special focus is placed on the protective actions of melatonin against IR injury in brain, heart, liver, and others. Finally, we explore several potential future directions of research in this area. Collectively, the information compiled here will serve as a comprehensive reference for the actions of melatonin in IR injury identified to date and will hopefully aid in the design of future research and increase the potential of melatonin as a therapeutic agent.     

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently respond to treatment with EGFR-targeted tyrosine kinase inhibitors (TKIs), such as erlotinib, but responses are not durable, as tumors acquire resistance. Secondary mutations in EGFR (such as T790M) or upregulation of the MET kinase are found in over 50% of resistant tumors. Here, we report increased activation of AXL and evidence for epithelial-to-mesenchymal transition (EMT) in multiple in vitro and in vivo EGFR-mutant lung cancer models with acquired resistance to erlotinib in the absence of the EGFR p.Thr790Met alteration or MET activation. Genetic or pharmacological inhibition of AXL restored sensitivity to erlotinib in these tumor models. Increased expression of AXL and, in some cases, of its ligand GAS6 was found in EGFR-mutant lung cancers obtained from individuals with acquired resistance to TKIs. These data identify AXL as a promising therapeutic target whose inhibition could prevent or overcome acquired resistance to EGFR TKIs in individuals with EGFR-mutant lung cancer.     

基于项目网络拆分决策的多项目协同调度问题建模

以大型工业品资源共享型节拍式流水装配过程为背景,提出基于项目网络拆分决策的多项目协同调度问题.根据装配过程作业的周期性调度需求,将单个项目的作业集合划分成共享资源的多个并行执行的协同子项目,以最小化节拍时间为目标,建立了项目网络拆分与项目调度同时决策的数学优化模型,设计了一种双层循环迭代算法以对模型进行求解.算法的上层是基于有效时序约束数量的作业划分构造型启发式算法,可在多项目网络之间调整作业的从属关系;算法的下层采用基于优先规则的启发式算法对上层拆分后的多项目网络进行求解,并将调度结果反馈至上层,通过循环迭代不断优化项目来调度计划.数据实验结果表明,所提算法能够有效提高资源利用率,且其求解质量和效率较高.